Japan opens mass vaccination centres two months before Olympic Games

Japan mobilised military doctors and nurses to give shots to elderly people in Tokyo and Osaka on Monday as the government desperately tries to accelerate its vaccination rollout and curb coronavirus

Tokyo Olympics
Photo: AP | PTI
AP Tokyo
3 min read Last Updated : May 24 2021 | 10:00 AM IST
Photo: AP | PTI

Japan mobilised military doctors and nurses to give shots to elderly people in Tokyo and Osaka on Monday as the government desperately tries to accelerate its vaccination rollout and curb coronavirus infections just two months before hosting the Olympics.

Prime Minister Yoshihide Suga is determined to hold the Olympics in Tokyo after a one-year delay and has made an ambitious pledge to finish vaccinating the country's 36 million elderly people by the end of July, despite scepticism it's possible.

Worries about public safety while many Japanese remain unvaccinated have prompted growing protests and calls for cancelling the Games set to start on July 23.

Suga's government has repeatedly expanded the area and duration of a virus state of emergency since late April and has made its virus-fighting measures stricter. But with COVID-19 cases still persistently high, Suga says vaccines are key to getting the infections under control.

At the two mass inoculation centres staffed by Japan's Self-Defence Forces, the aim is to inoculate up to 10,000 people per day in Tokyo and another 5,000 per day in Osaka for the next three months.

People inoculated at the centres on Monday were the first in Japan to receive doses from Moderna Inc, one of two foreign-developed vaccines Japan approved on Friday.

Previously Japan had used only Pfizer Inc, and only about 2% of the population of 126 million has received the required two doses.

Japan began vaccinating health care workers in mid-February while sticking to a standard requirement of clinical testing inside Japan a decision many experts said was statistically meaningless and only caused delay.

Vaccinations for the next group the elderly, who are more likely to suffer serious COVID-19 effects started in mid-April but has been slowed by bureaucratic bumbling including reservation procedures, unclear distribution plans and shortage of medical staff to give shots.

Completion of Japan-developed vaccines is still uncertain, but Japanese government officials hope the approvals Friday of Moderna and AstraZeneca will help speed up the rollout.

Progress is still unclear because of the dire shortage of medical staff who can give shots while they are already busy treating COVID-19 patients. AstraZeneca's plans are also pending due to concerns about its rare blood-clotting in a country known for low confidence in vaccines.

Separately, several local governments, including Aichi in central Japan and Gunma near Tokyo and Miyagi in the north, were also to open their own large vaccination centres on Monday.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Olympics2020 Tokyo olympicsCoronavirus Vaccine

First Published: May 24 2021 | 9:41 AM IST

Next Story